Where It Comes From
o-Toluidine hydrochloride is the hydrochloride salt of o-toluidine (2-methylaniline), formed by protonation of the amine nitrogen [1]. It is used in analytical chemistry as a standard for colorimetric assays (the o-toluidine blood glucose assay, now largely replaced by enzymatic methods), as a pharmaceutical intermediate, and in research settings [2]. Like its free base counterpart, it was used as a dye intermediate and in rubber chemical manufacturing. The toxicological concerns are identical to o-toluidine — metabolic N-hydroxylation produces reactive intermediates that form bladder DNA adducts [1].
How You Are Exposed
Laboratory chemists and pharmaceutical synthesis workers using o-toluidine hydrochloride as a reagent [1]. Historical exposure through o-toluidine-producing industries, particularly rubber antioxidant manufacturing (same cohort as o-toluidine free base) [2].
Why It Matters
In vivo, the hydrochloride proton dissociates, and o-toluidine hydrochloride behaves identically to the free base in terms of metabolic activation and carcinogenicity [1]. IARC Group 1 carcinogen (same classification as free base) [2].
Who Is at Risk
Laboratory chemists and pharmaceutical workers [1]. Same occupational cohort as o-toluidine in rubber manufacturing [2].
How to Lower Your Exposure
1. Handle in fume hood with impermeable gloves [1]. 2. Same precautions as o-toluidine free base [2].
References
- [1]IARC (2012). Monographs Volume 100F: o-Toluidine. https://monographs.iarc.fr/
- [2]EPA IRIS: o-Toluidine. https://iris.epa.gov/
Recovery & Clinical Information
Body Half-Life
Same as o-toluidine free base — blood half-life approximately 3-7 hours [1].
Testing & Biomarkers
Urine o-toluidine by GC-MS [1]. Urine cytology for bladder surveillance [2].
Interventions
Remove from exposure; bladder cancer surveillance for exposed workers [1].
Recovery Timeline
Same as o-toluidine — urine metabolites clear within 24-48 hours [1].
Recovery References
- [1]IARC (2012). Monographs Volume 100F. https://monographs.iarc.fr/
- [2]Carreón T et al. (2014). Bladder cancer incidence. https://doi.org/10.1093/jnci/dju159